• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR MITRACLIP SYSTEM STEERABLE GUIDE CATHETER; VALVE REPAIR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR MITRACLIP SYSTEM STEERABLE GUIDE CATHETER; VALVE REPAIR Back to Search Results
Model Number SGC0301
Device Problem Failure to Advance (2524)
Patient Problems Perforation (2001); Cardiac Tamponade (2226)
Event Date 09/21/2020
Event Type  Injury  
Manufacturer Narrative
The customer reported the device is not returning.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.
 
Event Description
This is filed to report the perforation.It was reported this was a mitraclip procedure performed to treat degenerative mitral regurgitation (mr) with a grade of 4+.During advancement of the steerable guide catheter (sgc) just a few centimeters into the femoral vein, resistance was felt with the stenotic vessel and a vein perforation was noted.The sgc was removed without issue.A vascular surgeon was called, and balloon tamponade was performed, followed by stent implantation, resolving the perforation.The mitraclip procedure was aborted.No clips were implanted, mr remained 4+.Per the physician, it cannot be said for certain which device caused the injury to the vein.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot.Additionally, a review of the complaint history identified no similar incidents reported from this lot.The reported patient effect of perforation as listed in the instructions for use, is a known possible complication associated with mitraclip procedures.Based on the information reviewed, the reported failure to advance-septum appears to be due to challenging patient anatomy (stenotic vessel).The cause for the reported patient effect of perforation could not be determined.The additional therapy non-surgical treatment was a result of case specific circumstances.There is no indication of a product issue with respect to manufacture, design, or labeling.Patient code 2226 - removed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP SYSTEM STEERABLE GUIDE CATHETER
Type of Device
VALVE REPAIR
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key10680937
MDR Text Key211437827
Report Number2024168-2020-08606
Device Sequence Number1
Product Code DRA
UDI-Device Identifier08717648216824
UDI-Public08717648216824
Combination Product (y/n)N
PMA/PMN Number
K161985
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 12/01/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/14/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/16/2021
Device Model NumberSGC0301
Device Catalogue NumberSGC0301
Device Lot Number00616U257
Was Device Available for Evaluation? No
Date Manufacturer Received11/12/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-